|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-7
|
|
pubmed:abstractText |
Pneumocystis jiroveci pneumonia (PCP) is a potentially fatal complication in interstitial pneumonia patients receiving glucocorticoid therapy. Prophylaxis of PCP during glucocorticoid therapy is an important issue in the treatment of interstitial pneumonia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1349-7235
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
15-20
|
|
pubmed:meshHeading |
pubmed-meshheading:18175999-Adult,
pubmed-meshheading:18175999-Aged,
pubmed-meshheading:18175999-Aged, 80 and over,
pubmed-meshheading:18175999-Anti-Infective Agents,
pubmed-meshheading:18175999-Antibiotic Prophylaxis,
pubmed-meshheading:18175999-CD4 Lymphocyte Count,
pubmed-meshheading:18175999-Female,
pubmed-meshheading:18175999-Glucocorticoids,
pubmed-meshheading:18175999-Humans,
pubmed-meshheading:18175999-Lung Diseases, Interstitial,
pubmed-meshheading:18175999-Male,
pubmed-meshheading:18175999-Middle Aged,
pubmed-meshheading:18175999-Pneumocystis jirovecii,
pubmed-meshheading:18175999-Pneumonia, Pneumocystis,
pubmed-meshheading:18175999-Prednisolone,
pubmed-meshheading:18175999-Retrospective Studies,
pubmed-meshheading:18175999-Treatment Outcome,
pubmed-meshheading:18175999-Trimethoprim-Sulfamethoxazole Combination
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Tokyo Metropolitan Hiroo General Hospital, Tokyo.
|
|
pubmed:publicationType |
Journal Article
|
